Central Region, Central, Singapore The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2018. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Among the various public portfolio startups of the fund, we may underline MyRepublic, Doctor Anywhere Among the most successful fund investment fields, there are ISP, Internet. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the Kamet Capital Partners, startups are often financed by Xavier Niel, Sunshine Network, Makara Capital. The meaningful sponsors for the fund in investment in the same round are CLSA Capital Partners.
We also calculated 1 valuable employee in our database.
| Fund Name | Location |
| Applied Micro Circuits | California, Sunnyvale, United States |
| AquilaDirekt | Switzerland, Zürich, Zurich |
| ARC Capital | China, Hong Kong, Hong Kong Island |
| Dingxin Chuangtou | Anhui, China, Hefei |
| Genesis Block | Provo, United States, Utah |
| Harpoon | California, Menlo Park, United States |
| Seed Capital Fund of CNY | New York, Syracuse, United States |
| Startup Autobahn | Baden-Wurttemberg, Germany, Stuttgart |
| Stax Inc | Boston, Massachusetts, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
LMS365 | $20M | 13 Apr 2023 | Århus, Midtjylland, Denmark | ||
Doctor Anywhere | $38M | 21 Dec 2022 | Singapore, Central, Singapore | ||
TraMes | $1M | 28 Sep 2020 | Singapore, Central, Singapore | ||
Doctor Anywhere | $27M | 31 Mar 2020 | Central | ||
Doctor Anywhere | $4M | 02 Jul 2018 | Central |
– Doctor Anywhere from Singapore develops a tech-led healthcare company.
– The company raised US$65.7M in Series C funding.
– The round was led by Asia Partners and also joined by Novo Holdings A/S, Philips Venture, OSK-SBI Ventures and existing investors Square Peg, EDBI, IHH Healthcare, Kamet Capital and Pavilion Capital.
– The new investment will be used to bolster the company’s market leadership, to further deepen its presence in its existing markets, and to expand into new markets.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
LMS365 | $20M | 13 Apr 2023 | Århus, Midtjylland, Denmark | ||
Doctor Anywhere | $38M | 21 Dec 2022 | Singapore, Central, Singapore | ||
TraMes | $1M | 28 Sep 2020 | Singapore, Central, Singapore | ||
Doctor Anywhere | $27M | 31 Mar 2020 | Central | ||
Doctor Anywhere | $4M | 02 Jul 2018 | Central |
